Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 6Prostatic Neoplasms 3Multiple Myeloma 3Colorectal Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 2Rectal Neoplasms 2Neoplasms, Plasma Cell 2Neoplasms 2Melanoma 2Glioblastoma 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma 2Solid Tumor 1Sarcoma, Clear Cell 1Refractory or Relapsed Solid Tumors 1Platinum-resistant Epithelial Ovarian Cancer 1Neoplasm Metastasis 1Malignant Solid Tumour 1Lymphangioleiomyomatosis 1Lung Neoplasms 1Liver Neoplasms 1Klatskin Tumor 1Gliosarcoma 1Gastrointestinal Neoplasms 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Arthritis, Rheumatoid 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Sorafenib 42Bevacizumab 16Oxaliplatin 13Radiosurgery 10Gemcitabine 10Doxorubicin 10Capecitabine 10Leucovorin 9Hepatectomy 9Fluorouracil 9Cisplatin 9Radiofrequency Ablation 8Nivolumab 8pembrolizumab 7Drug Therapy 7Carboplatin 7Irinotecan 6Cryosurgery 6Talaporfin 5Mitomycin 5Everolimus 5Erlotinib Hydrochloride 5Electroporation 5spartalizumab 4Sunitinib 4Melphalan 4Ipilimumab 4Epirubicin 4Embolization, Therapeutic 4regorafenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Liver Neoplasms × Hydroxychloroquine × Clear all
NCT03037437 2025-09-04

Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer

The University of Texas Health Science Center at San Antonio

Phase 2 Completed
64 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡